Cochlear Limited (ASX:COH)
Australia · Delayed Price · Currency is AUD 143.64
+1.44 (1.01%)
Oct 30, 2026, 4:10 PM AEDT
Cochlear Market Cap
Cochlear has a market cap or net worth of 9.39 billion as of October 30, 2026. It is the 2,880th most valuable company in the world and the 53rd biggest in Australia. Its market cap has decreased by 50.43% in one year.
Market Cap
9.39B
Enterprise Value
9.42B
Revenue
2.35B
Global Rank
Country Rank
#53 Australia
PE Ratio
63.90
ChartMarket Cap Chart
Since December 12, 1995, Cochlear's market cap has increased from 44.18M to 9.39B, an increase of 21,163.17%. That is a compound annual growth rate of 18.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 9.39B | -44.89% |
| Dec 31, 2025 | 17.05B | -10.12% |
| Dec 31, 2024 | 18.97B | -3.04% |
| Dec 29, 2023 | 19.56B | 45.68% |
| Dec 30, 2022 | 13.43B | -5.54% |
| Dec 31, 2021 | 14.22B | 14.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 4DMedical | 1.47B |
| PolyNovo | 625.21M |
| Imricor Medical Systems | 484.18M |
| Aroa Biosurgery | 190.25M |
| EMVision Medical Devices | 139.67M |
| EBR Systems | 109.91M |
| SomnoMed | 63.73M |
| Saluda Medical | 61.75M |